Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep380 | Clinical case reports - Thyroid/Others | ECE2016

Unusual presentation of primary hyperparathyroidism with coexisted thyroid carcinoma

Basaran Yalcin , Ince Semra , Alagoz Engin , Meric Coskun , Taslipinar Abdullah

Introduction: Brown tumor is a rare benign bone lesion with incidence ranging from 1.5% in primary hyperparathyroidism to 13% in secondary hyperparathyroidism. Common sites of involvement are pelvis, femur and ribs, but may appear in any bone. Since the incidence of thyroid disease is higher among patients with hyperparathyroidism than the general population, these lesions must be distinguished from metastases from thyroid carcinoma.We present a patient ...

ea0041ep542 | Diabetes therapy | ECE2016

Add on exenatide treatment in obese type 2 diabetic patients under intensive insulin regiments

Sonmez Alper , Dinc Mustafa , Taslipinar Abdullah , Aydogdu Aydogan , Meric Coskun , Basaran Yalcin , Haymana Cem , Demir Orhan , Azal Omer

Introduction: Intensive insulin treatment in obese patients with type 2 diabetes (T2DM) is often difficult. Insulin dosages are much higher, which further increase weight gain and the risk of hypoglycemia. Glucagon like peptide 1 receptor agonists (GLP-1RAs) are the promising treatment modalities causing weight loss and reducing the risk of hypoglycemia. There is no published data about the effect of adding on GLP1RAs to obese T2DM patients with un-controlled glucose levels un...

ea0049ep1165 | Male Reproduction | ECE2017

Endothelial dysfunction, inflammation and insulin resistance in patients with Klinefelter Syndrome

Haymana Cem , Aydogdu Aydogan , Demirci Ibrahim , Dinc Mustafa , Demir Orhan , Torun Deniz , Yesildal Fatih , Meric Coskun , Basaran Yalcin , Sonmez Alper , Azal Omer

Introduction: The prevalence of cardiometabolic disorders such as type 2 diabetes mellitus, dysipidemia and metabolic syndrome is increased in patients with Klinefelter syndrome (KS). The mechanism by which cardiometabolic risk increases in patients with KS remains to be completely elucidated. We investigated the presence of inflammation, insulin resistance and endothelial dysfunction in an unconfounded population of KS.Methods: A total of 31 patients wi...

ea0041ep716 | Male Reproduction | ECE2016

The investigation of oxidative stress-related parameters in congenital hypogonadism

Haymana Cem , Aydogdu Aydogan , Soykut Bugra , Erdem Onur , Ibrahimov Tural , Dinc Mustafa , Meric Coskun , Taslipinar Abdullah , Basaran Yalcin , Sonmez Alper , Azal Omer

Introduction: Patients with hypogonadism are at increased risk of cardiac and metabolic diseases. The pathogenesis of increased cardio-metabolic risk in hypogonadal patients is not clear. Oxidative stress plays an important role in the pathogenesis of cardio-metabolic diseases. The aim of this study was to search for any difference of the oxidative stress parameters between in patients with hypogonadism and healthy controls.Materials and Methods: Thirty ...

ea0032p186 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

The effect of testosterone replacement on endothelial dysfunction, inflammation and insulin resistance in male hypogonadotrophic hypogonadism

Sonmez Alper , Taslipinar Abdullah , Aydogdu Aydogan , Tapan Serkan , Meric Coskun , Basaran Yalcin , Sertoglu Erdim , Yilmaz Mahmut I , Serdar Muhittin A , Ozgurtas Taner , Bolu Erol , Kutlu Mustafa

Objective: Metabolic disorders are common in patients with hypogonadism. Testosterone replacement therapy (TRT) significantly improves symptoms of testosterone deprivation such as mood, libido or musculoscelatal power. However, whether the metabolic and cardiovascular risk is improved is not clearly known. We aimed to search for the metabolic and cardiovascular effects of TRT.Design: Prospective study, performed in the outpatient units of Gulhane Medical...

ea0032p193 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism

Bolu Erol , Sonmez Alper , Tapan Serkan , Taslipinar Abdullah , Aydogdu Aydogan , Meric Coskun , Basaran Yalcin , Uckaya Gokhan , Serdar Muhittin A , Kurt Ismail , Azal Omer

Metabolic disorders and cardiovascular events are increased in hypogonadism. Serum HDL composition is a better cardiovascular predictor than the HDL counts. However, there is no information about the HDL subfractions in patients with hypogonadism. We designed a prospective study to investigate the HDL subfractions in treatment naïve subjects with hypogonadism and the effects of two different testosterone replacement regimens on the HDL subfractions. Seventy young male pat...